Skip to content
Screener

NeoGenomics NEO Net Income

Net Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-34,000%
Labcorp Holdings logo
Labcorp HoldingsLH
$298.7M+25.6%
Quest Diagnostics logo
Quest DiagnosticsDGX
$320M+13.5%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$7.27M+36.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.03M-90.7%
Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%

Segments

By segment

See full
Reportable Segment$2.24M+105%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2B+182%
Enterprise value$2.3B+268%
P/S2.6×+1.6×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Gain on extinguishment of debt (Note 6)11,18111,181
Income (loss) before taxes1,826(45,816)(15,752)(71,473)
Income tax benefit412724884458
NET INCOME (LOSS)$2,238$(45,092)$(14,868)$(71,015)
NET INCOME (LOSS) PER SHARE
Basic$0.02$(0.35)$(0.11)$(0.56)
Diluted$0.02$(0.35)$(0.11)$(0.56)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's net income?
NeoGenomics (NEO) reported net income of $2.24M in Q2 2026.
How has NeoGenomics's net income changed year-over-year?
NeoGenomics's net income increased by 105.0% year-over-year, from -$45.09M to $2.24M.
What is the long-term trend for NeoGenomics's net income?
Over 4 years (2021 to 2025), NeoGenomics's net income has grown at a 89.7% compound annual growth rate (CAGR), from -$8.35M to -$108.03M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about NeoGenomics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude